Objective-To obtain information on the incidence of rheumatoid arthritis and on its recent trends in Finland.
The cause of rheumatoid arthritis is unknown. No place or ethnic group appears to be free of this disease, at least when population studies have been large enough to provide reliable estimates of its occurrence.' The prevalence of rheumatoid arthritis is about 0.5-1.0% of the adult population in most western countries. On the other hand, rheumatoid arthritis may be rare in rural populations in tropical areas.
For many purposes, incidence is a more useful measure of disease occurrence than prevalence. Problems occur, however, in conducting incidence studies of rheumatoid arthritis. In Caucasian populations the annual incidence of definite rheumatoid arthritis appears to lie at between 25 and 50 per 100 000 of the adult population,"4 yet appreciably lower figures have been reported from France. 7 Only two of the above studies2 6 were truly population based. A much higher incidence of rheumatoid arthritis than in Caucasian populations has been noted in Pima Indians.!
Figures reflecting the incidence of chronic inflammatory rheumatic diseases are available in Finland from the nationwide register of the sickness insurance scheme. We report recent trends in the incidence of rheumatoid arthritis in Finland, using these data as a basis. A small decline occurred in the number of rheumatoid arthritis cases in 1990 compared with the earlier years; however, when RF negative cases were considered separately the decline was significant (RF negative rheumatoid arthritis, P = 0.008; RF negative polyarthritis, P = 0.013). The decline was more marked in males than in females. All the five study areas behaved in a similar fashion.
Methods

Discussion
The annual incidence of arthritis diagnosed in the reimbursement certificates as rheumatoid arthritis was 46/100 000 of the adult population, corresponding to 1820 cases per Kaipiainen-Seppanen, Aho, Isomaki, Laakso year. In another study from Finland, a total of 1666 subjects entitled to specially reimbursed medication for rheumatoid arthritis died in 1989.12 The number of new cases was thus about the same as the number of rheumatoid arthritis cases among those who had died (42/ 100 000).
A small error occurred in the incidence rates since relevant information was lacking in about 2% of the cases known to have entitlement because of chronic inflammatory rheumatic diseases; most of these cases were from the year 1980. The period from the onset of symptoms to the entitlement was slightly shorter in 1990 than in the earlier study years. Without this reduction in the onset to registration time the incidence rates for the year 1990 would have been slightly lower than those observed.
A proportion ofpatients diagnosed as having rheumatoid arthritis on the reimbursement certificate do not have this disease according to commonly accepted criteria. The incidence of rheumatoid arthritis in 1980 and 1985 satisfying the ARA 1987 classification criteria was 39/100 000 of the adult population. This figure, however, underestimates the true incidence to some degree, in that not all patients with rheumatoid arthritis are entitled to specially reimbursed medication. In recent years, the great majority of patients have ultimately gained this eligibility" but a considerable delay can occur, particularly in patients with insidious onset. The ARA 1-987 classification criteria were also defined on the basis of cases with long lasting disease, and the criteria do not allow for inclusion of a proportion of cases with recent onset.'4 Patient records were also not keyed to the ARA criteria; in particular, information concerning morning stiffness was frequently lacking. On the other hand, RF status was known in all cases.
In addition to use of the ARA 1987 criteria, we divided the cases considered to have rheumatoid arthritis into three groups: those with RF positive arthritis, RF negative polyarthritis, and RF negative oligoarthritis. In an earlier community based follow up study of recent onset arthritis from Finland, the great majority of RF positive arthritis patients developed erosive disease, whereas virtually all patients with RF negative oligoarthritis attained remission.°The outcome of RF negative polyarthritis was bimodal: a majority of patients had a favourable outcome and a minority did not do well. The Thus the declining trend in RF negative rheumatoid arthritis probably is a true phenomenon. One underlying mechanism might be related to selenium. For geochemical reasons Finland is a low selenium area. The serum levels were especially low in years when the intake depended solely on domestic grain. '7 In 1984 it was decided to add selenium to multimineral fertilisers to increase the selenium intake of the population. As a result the mean serum selenium levels of healthy adults increased markedly.'8 We have earlier presented preliminary evidence that low serum selenium levels may predict the development of rheumatoid arthritis.'9 In a subsequent larger series this finding was confirmed but the association was confined to RF negative disease (to be published). 
